A couple of years ago, I was at a conference at Ohio State’s Moritz School of Law on harm reduction strategies for the opioid crisis. One of the speakers was Dr. Dan Rosenblum, a health economist from Dalhousie University in Nova Scotia who specializes in both development economics and illicit drug markets. At this conference […]
